MDL TrackerAntitrust

Nitrogen, Phosphorus, and Potassium (NPK) Fertilizer

MDL No. 3187  ·  U.S. District Court for the District of Kansas
MDL No.
3187
Docket Type
Antitrust
Transferee Judge
Hon. Eric F. Melgren
Centralized
2026-06-09
Actions Pending
37
As Of
2026-09-01
Funding Considerations

Nitrogen, Phosphorus, and Potassium (NPK) Fertilizer Antitrust Litigation alleges that major fertilizer producers coordinated on pricing and output restriction across the primary nutrient categories used in commercial agriculture, inflating prices paid by farmers, agricultural retailers, and distributors. Centralized in the District of Kansas in June 2026, the docket carries 37 pending actions just three months after centralization, reflecting quick recognition of the alleged conduct across a broad agricultural purchaser base.

For a funder, this is a very early-stage matter — centralized only months before the current report — where claim files are necessarily thin and the docket's own class-certification and damages-methodology record has not yet developed. Farmers, agricultural retailers, and distributors with documented fertilizer purchase volumes during the relevant period are the relevant claimant pool, a commercial claim funding conversation rather than a medical-lien matter.

Given the early phase, portfolio finance across a broad claimant pool is premature; single-matter or small-group litigation-cost funding under Criterica Capital's commercial litigation finance line is the more realistic near-term structure, with terms reflecting the substantial uncertainty that remains around market definition (given that nitrogen, phosphorus, and potassium fertilizers may be treated as separate product markets) and the eventual shape of any certified class. A structure and litigation brief tracking this docket's early development is also available.

Frequently Asked Questions
Is the claim record developed enough to fund confidently in this docket?
+
Can a farmer or agricultural retailer get funding on a fertilizer-purchaser claim?
+
Is portfolio finance realistic for a group of purchasers now?
+
What Criterica Capital product fits this docket at its current phase?
+

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.

Litigation structure and resolution-risk brief on Criterica Intelligence →
Holding Nitrogen, Phosphorus, and Potassium (NPK) Fertilizer claims or inventory?
Send the details and our institutional team will respond within one business day.